These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9420673)

  • 1. Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events.
    Miller DD; Stratmann HG; Shaw L; Tamesis BR; Wittry MD; Younis LT; Chaitman BR
    J Nucl Cardiol; 1994; 1(1):72-82. PubMed ID: 9420673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina.
    Stratmann HG; Tamesis BR; Younis LT; Wittry MD; Amato M; Miller DD
    Am Heart J; 1995 Oct; 130(4):734-40. PubMed ID: 7572580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain.
    Stratmann HG; Williams GA; Wittry MD; Chaitman BR; Miller DD
    Circulation; 1994 Feb; 89(2):615-22. PubMed ID: 8313549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events.
    Stratmann HG; Younis LT; Wittry MD; Amato M; Miller DD
    Am Heart J; 1996 May; 131(5):923-9. PubMed ID: 8615311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative cardiac risk stratification before major or minor nonvascular surgery.
    Stratmann HG; Younis LT; Wittry MD; Amato M; Mark AL; Miller DD
    Am Heart J; 1996 Sep; 132(3):536-41. PubMed ID: 8800022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise.
    Stratmann HG; Tamesis BR; Younis LT; Wittry MD; Miller DD
    Am J Cardiol; 1994 Apr; 73(9):647-52. PubMed ID: 8166059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events.
    McClellan JR; Travin MI; Herman SD; Baron JI; Golub RJ; Gallagher JJ; Waters D; Heller GV
    Am J Cardiol; 1997 Mar; 79(5):600-5. PubMed ID: 9068516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions.
    Heller GV; Herman SD; Travin MI; Baron JI; Santos-Ocampo C; McClellan JR
    J Am Coll Cardiol; 1995 Nov; 26(5):1202-8. PubMed ID: 7594033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris.
    Stratmann HG; Younis LT; Wittry MD; Amato M; Miller DD
    Am J Cardiol; 1995 Aug; 76(4):236-40. PubMed ID: 7618615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognostic value of exercise 99mTc-MIBI SPET myocardial perfusion imaging in patients after percutaneous coronary intervention.
    Zhang X; Liu X; He ZX; Shi R; Yang M; Gao R; Chen J; Yang Y; Fang W
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):655-62. PubMed ID: 14740177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification with pre-hospital discharge exercise technetium-99m sestamibi myocardial tomography in men after acute myocardial infarction.
    Stratmann HG; Mark AL; Amato M; Wittry MD; Younis LT
    Am Heart J; 1998 Jul; 136(1):87-93. PubMed ID: 9665223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain.
    Geleijnse ML; Elhendy A; van Domburg RT; Cornel JH; Reijs AE; Roelandt JR; Krenning EP; Fioretti PM
    J Am Coll Cardiol; 1996 Aug; 28(2):447-54. PubMed ID: 8800124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction.
    van Daele ME; McNeill AJ; Fioretti PM; Salustri A; Pozzoli MM; el-Said ES; Reijs AE; McFalls EO; Slagboom T; Roelandt JR
    J Am Soc Echocardiogr; 1994; 7(4):370-80. PubMed ID: 7917345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.
    De Lorenzo A; Lima RS; Siqueira-Filho AG; Pantoja MR
    Am J Cardiol; 2002 Oct; 90(8):827-32. PubMed ID: 12372568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography.
    Berman DS; Hachamovitch R; Kiat H; Cohen I; Cabico JA; Wang FP; Friedman JD; Germano G; Van Train K; Diamond GA
    J Am Coll Cardiol; 1995 Sep; 26(3):639-47. PubMed ID: 7642853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of single-tracer (technetium-99m-sestamibi) and dual-tracer (thallium-201 chloride and technetium-99m-sestamibi) protocols for identification of myocardial ischemia.
    Loutfi I; Singh A
    Invest Radiol; 1995 Jun; 30(6):367-71. PubMed ID: 7490189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS).
    Heller GV; Brown KA; Landin RJ; Haber SB
    Am Heart J; 1997 Jul; 134(1):105-11. PubMed ID: 9266790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental prognostic value of myocardial perfusion 99m-technetium-sestamibi SPECT in the elderly.
    Lima RS; De Lorenzo A; Pantoja MR; Siqueira A
    Int J Cardiol; 2004 Feb; 93(2-3):137-43. PubMed ID: 14975539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility and prognostic value of dipyridamole technetium-99m sestamibi myocardial perfusion imaging SPECT in predicting perioperative cardiac events following non-cardiac surgery.
    Asli IN; Shahoseini R; Azizmohammadi Z; Javadi H; Assadi M
    Perfusion; 2013 Jul; 28(4):333-9. PubMed ID: 23482483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.